Cathleen Wilbur

Cathleen Wilbur has worked in various roles within the pharmaceutical industry. Cathleen'smost recent position was as the Senior Director of Project Management at Taiho Oncology, Inc. since April 2019. Prior to that, they were the Associate Director of Global Portfolio Management at Prolong Pharmaceuticals from April 2018 to March 2019. Cathleen also held the role of Associate Director of Global Project and Alliance Management at Merck from June 2016 to February 2018. Before that, they were the Associate Director of Clinical Project Leadership at BioMarin Pharmaceutical Inc. from September 2015 to May 2016. Cathleen also worked for Genentech as a Senior Global Project Manager from February 2007 to August 2015. Cathleen started their career at Celgene as a Project Manager in the Cellular Therapeutics Division. At Celgene, Cathleen managed cross-functional initiatives through all phases of development and played a key role in achieving ISO certification. Cathleen also worked as a Project Manager in Medical Affairs at Pfizer Pharmaceuticals from 2002 to 2003.

Cathleen Wilbur's education history includes a Bachelor of Arts degree in Psychology and Elementary Education from Moravian University. The start and end years of their education are unknown.